These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37130168)

  • 1. The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING.
    Cao D; Duan L; Huang B; Xiong Y; Zhang G; Huang H
    Sci Signal; 2023 May; 16(783):eadd0082. PubMed ID: 37130168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex.
    Chen X; Yang X; Zheng Y; Yang Y; Xing Y; Chen Z
    Protein Cell; 2014 May; 5(5):369-81. PubMed ID: 24622840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner.
    Ran XH; Zhu JW; Chen YY; Ni RZ; Mu D
    Front Immunol; 2022; 13():947272. PubMed ID: 36032116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
    Shin D; Mukherjee R; Grewe D; Bojkova D; Baek K; Bhattacharya A; Schulz L; Widera M; Mehdipour AR; Tascher G; Geurink PP; Wilhelm A; van der Heden van Noort GJ; Ovaa H; Müller S; Knobeloch KP; Rajalingam K; Schulman BA; Cinatl J; Hummer G; Ciesek S; Dikic I
    Nature; 2020 Nov; 587(7835):657-662. PubMed ID: 32726803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling.
    Sun L; Xing Y; Chen X; Zheng Y; Yang Y; Nichols DB; Clementz MA; Banach BS; Li K; Baker SC; Chen Z
    PLoS One; 2012; 7(2):e30802. PubMed ID: 22312431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.
    Báez-Santos YM; Mielech AM; Deng X; Baker S; Mesecar AD
    J Virol; 2014 Nov; 88(21):12511-27. PubMed ID: 25142582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-cov-2 PLpro.
    Liu X; Zheng M; Zhang H; Feng B; Li J; Zhang Y; Zhang J; Zhao N; Li C; Song N; Song B; Yang D; Chen J; Qi A; Zhao L; Luo C; Zang Y; Liu H; Li J; Zhang B; Zhou Y; Zheng J
    Antiviral Res; 2024 Aug; 228():105944. PubMed ID: 38914283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
    Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
    J Virol; 2021 May; 95(12):. PubMed ID: 33789998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
    Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
    J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between SARS coronavirus 2 papain-like protease and immune system: A potential drug target for the treatment of COVID-19.
    Mahmoudvand S; Shokri S
    Scand J Immunol; 2021 Oct; 94(4):e13044. PubMed ID: 33872387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The substrate selectivity of papain-like proteases from human-infecting coronaviruses correlates with innate immune suppression.
    Xiong Y; Huang B; Yang Y; Fu X; Fu Z; Xu H; Liu M; Cao D; Zhang M; Yang H; Niu X; Yu C; Huang H
    Sci Signal; 2023 May; 16(783):eade1985. PubMed ID: 37130166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease.
    Choudhary S; Nehul S; Singh A; Panda PK; Kumar P; Sharma GK; Tomar S
    IUBMB Life; 2024 May; 76(5):228-241. PubMed ID: 38059400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo.
    van Huizen M; Bloeme-Ter Horst JR; de Gruyter HLM; Geurink PP; van der Heden van Noort GJ; Knaap RCM; Nelemans T; Ogando NS; Leijs AA; Urakova N; Mark BL; Snijder EJ; Myeni SK; Kikkert M
    PLoS Pathog; 2024 Mar; 20(3):e1012100. PubMed ID: 38527094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective inhibition of coronavirus replication by
    Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting papain-like protease for broad-spectrum coronavirus inhibition.
    Yuan S; Gao X; Tang K; Cai JP; Hu M; Luo P; Wen L; Ye ZW; Luo C; Tsang JO; Chan CC; Huang Y; Cao J; Liang R; Qin Z; Qin B; Yin F; Chu H; Jin DY; Sun R; Chan JF; Cui S; Yuen KY
    Protein Cell; 2022 Dec; 13(12):940-953. PubMed ID: 35384604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmissible Gastroenteritis Virus Papain-Like Protease 1 Antagonizes Production of Interferon-
    Hu X; Tian J; Kang H; Guo D; Liu J; Liu D; Jiang Q; Li Z; Qu J; Qu L
    Biomed Res Int; 2017; 2017():7089091. PubMed ID: 29201911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities.
    Mielech AM; Kilianski A; Baez-Santos YM; Mesecar AD; Baker SC
    Virology; 2014 Feb; 450-451():64-70. PubMed ID: 24503068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
    Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
    Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.